S&P Pharmaceutical Industry Company Limited - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for S&P Pharmaceutical Industry Company Limited Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

S&P Pharmaceutical Industry Company Limited Formerly known as Qinghai Sunshine & People Pharmaceutical Company Limited. The Group's principal activities are the research, development, manufacture and sale of Chinese and Tibetan medicines and health products. Other activities include the wholesale and retail of Chinese and Western medicines, biological products, medicinal and chemical raw materials, medical apparatus and equipment and daily-use chemicals. The Group's major brand is 'Sanpu' and major products include Chongcaojing (an essence made from Chinese caterpillar fungus), Yiganjian (hepatitis medicine) and Xinnaoxin (Tibetan medicine for diseases caused by shortage of oxygen). Operations of the Group are carried out in the People's Republic of China.

Not the Report you are looking for? Click here for more browsing options.

$600/yr | Annual Subscription | Premium Access to more than 150,000 company reports for $600/year**

$59.99/mo | Monthly Subscription | Premium Access to more than 150,000 company reports for $59.99/month**

$39.95 | ALL Reports on this company | Buy all reports for S&P Pharmaceutical

$24.95 | Single Sales Analysis Report | Buy this S&P Pharmaceutical Sales Analysis

Set Currency* Argentinian Pesos Australian Dollars Bermudan Dollars Brazilian Reals Canadian Dollars Chilean Pesos Chinese Renmimbi Colombian Pesos Czech Koruni Danish Kroner Dirham Egyptian Pounds Euro Hong Kong Dollars Hungarian Forints Icelandic Kronas Indian Rupees Indonesian Rupiahs Israel Shekels Japanese Yen Jordanian Dinars Korean Won Malaysian Ringgits Mexican Pesos Moroccan Dirhams New Zealand Dollars Norwegian Kroner Pakistan Rupees Peruvian New Sols Philippine Pesos Polish New Zlotys Pounds Sterling Russian Rubles Saudi Riyals Singapore Dollars Slovak Koruni South African Rands Sri Lanka Rupees Swedish Kronor Swiss Francs Taiwanese Dollars Thai Bahts Turkish Liras U.S. Dollars Venezuelan Bolivars Zimbabwe Dollars * If a currency is not selected, the report will be delivered in the local currency of the company ** Premium access limits users to 500 reports per month

Layout and Content of a Typical Report